Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, December 2008, p. 4507-4509, Vol. 52, No. 12
0066-4804/08/$08.00+0 doi:10.1128/AAC.00915-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Genetic Characterization of Vga ABC Proteins Conferring Reduced Susceptibility to Pleuromutilins in Staphylococcus aureus
Daniel R. Gentry,*
Lynn McCloskey,
Michael N. Gwynn,
Stephen F. Rittenhouse,
Nicole Scangarella,
Ribhi Shawar, and
David J. Holmes
Department of Microbiology, ID-CEDD, GlaxoSmithKline, Collegeville, Pennsylvania 19426
Received 10 July 2008/
Returned for modification 1 September 2008/
Accepted 29 September 2008

ABSTRACT
Retapamulin MICs of

2 µg/ml were noted for 6 of 5,676
S. aureus recent clinical isolates evaluated. The ABC proteins
VgaAv and VgaA were found to be responsible for the reduced
susceptibility to pleuromutilins exhibited by these six isolates.

TEXT
Members of the pleuromutilin class of antibiotics selectively
inhibit bacterial protein synthesis through interaction with
prokaryotic ribosomes (
11) and are structurally distinct from
other classes of ribosome inhibitors. While the pleuromutilins
tiamulin and valnemulin have found uses in veterinary applications,
retapamulin (formerly SB-275833) is the only member of this
class approved for use in humans (
9). Currently, retapamulin
is approved in countries including the United States for topical
use to treat impetigo, a highly contagious skin infection typically
caused by
Staphylococcus aureus or
Staphylococcus pyogenes.
The development of resistance to available antibiotics is a major medical issue that has spurred on the development of drugs such as retapamulin. Unfortunately, the development of resistance to any antibiotic is inevitable, thereby making an understanding of emerging resistance mechanisms important for the future development of antibiotics and diagnostic tools for detection. For these reasons, we have investigated the mechanism of decreased susceptibility to pleuromutilins among staphylococci in the GlaxoSmithKline strain collection, as well as isolates collected from retapamulin profiling of recent clinical isolates.
S. aureus strain RN1024 from the GlaxoSmithKline strain collection was identified during antimicrobial profiling of experimental compounds as being less susceptible to pleuromutilins. It was originally isolated in 1992 from a patient in northern France. A pleuromutilin-susceptible variant of this strain, RN1024-tms, was isolated, and subtractive-suppressive PCR (1) was carried out to generate a library enriched for DNA present in RN1024 but not RN1024-tms. Of 14 clones from the library that were sequenced, 10 were found to be identical to a fragment of the tnpA gene of the S. aureus transposon Tn5406 (5). Tn5406 is a small insertion element of 5,467 bp. It possesses four genes, tnpA, tnpB, tnpC, and vgaAv (5). Using PCR and gene-specific primers, we could detect each of the Tn5406-specific genes in RN1024 but not in RN1024-tms (data not shown). Tn5406 preferentially inserts into the chromosomal locus att554. We used primers that flank att554 to show that RN1024 carries a single copy of Tn5406 at this site, while RN1024-tms no longer carries the insertion (Fig. 1).
Of the genes present on Tn
5406,
vgaAv is the only one not associated
with transposon function, implicating it as the locus responsible
for the decreased pleuromutilin sensitivity of RN1024. The plasmid
pCU1-vgaAv, which consists of
vgaAv and 660 bp of upstream DNA
cloned into the
Escherichia coli/
S. aureus shuttle vector pCU1
(
2), was constructed to test whether VgaAv can affect pleuromutilin
MICs. pCU1-vgaAv was introduced into the laboratory strain
S. aureus RN4220 (
2,
6), and MICs were measured. Retapamulin and
tiamulin MICs are considerably higher in RN4220 (pCU1-vgaAv)
than in the control strain, RN4220 (pCU1) (see Table
2). Based
on the findings that RN1024-tms lacks Tn
5406 and that pCU1-vgaAv
decreases pleuromutilin sensitivity, we conclude that
vgaAv is responsible for the decreased pleuromutilin sensitivity of
RN1024. Pleuromutilin MICs are significantly higher for RN4220
(pCU1-vgaAv) than for RN1024. This is likely due to copy number,
as RN1024 carries a single copy of
vgaAv while RN4220 (pCU1-vgaAv)
carries multiple copies.
As part of the evaluations conducted during preclinical development,
the potency of retapamulin was measured against multiple laboratory
collections of recent clinical isolates (
10). These combined
studies identified six
S. aureus strains with retapamulin MICs
of

2 µg/ml. In five of these strains, the MICs ranged
from 2 to 4 µg/ml. The MIC of the remaining strain was
64 µg/ml (Table
1). Using
vgaAv-specific primers,
vgaAv was detected in the five strains with retapamulin MICs between
2 and 4 µg/ml. The results of PCR and sequence analysis
indicated that, like RN1024, all five strains carried Tn
5406 inserted into the
att554 site (data not shown).
vgaAv was not detected in
S. aureus IV20217033 (retapamulin
MIC, 64 µg/ml) but the homologous gene
vgaA was detected
by using
vgaA-specific primers. Plasmid DNA from this strain
transformed RN4220 to tiamulin resistance, indicating that the
resistance determinant was plasmid borne. Suspecting that the
plasmid encoded VgaA, we determined its complete sequence, named
here pVGA (5.9 kb), and confirmed the presence of
vgaA. In addition
to
vgaA, pVGA contains genes predicted to encode replication
and mobilization functions and no other antibiotic resistance
genes. pVGA-encoded VgaA varies by a single amino acid from
a VgaA isoform (
7,
8) so far only identified among coagulase-negative
staphylococci. The higher retapamulin MIC of IV20217033 relative
to those of RN1024 and the other isolates is likely due to the
presence of
vgaA in a higher copy number than the chromosomally
encoded VgaAv. Consistent with this, the pleuromutilin MIC of
RN4220 (pCU1-vgaAv), i.e.,
vgaAv in a high copy number, is comparable
with that of RN4220 (pVGA) (Table
2).
VgaA and VgaAv are members of the ATP-binding cassette (ABC) family of proteins and are likely involved in drug efflux (3). VgaA and VgaAv, which are 83% identical (5), have been shown to confer decreased sensitivity to two classes of protein synthesis inhibitors—lincosamides and streptogramin A compounds (4, 5). Streptogramins are mixtures of two unrelated classes of bacterial protein synthesis inhibitors, streptogramin A and streptogramin B, which act synergistically. As shown by the data in Table 2, of 16 antibiotics tested, the presence of pCU-vgaAv and pVGA in an isogenic background greatly increased the MICs of pleuromutilins, lincosamides (lincomycin and clindamycin), and a streptogramin A (dalfopristin). Quinupristin-dalfopristin (Synercid) MICs are also slightly higher in these strains, likely because of their higher dalfopristin MICs. Also shown by the data in Table 2, in addition to being more susceptible to pleuromutilins, RN1024-tms is more susceptible to lincosamides and dalfopristin than its Tn5406-carrying parent. These combined MIC data are consistent with our conclusion that the Vga proteins, in addition to conferring streptogramin A and lincosamide resistance, also confer reduced susceptibility to pleuromutilins.
Of 5,676 recent S. aureus clinical isolates evaluated (10), taken from pooled data from eight preclinical studies, one global surveillance study, and five phase III clinical trials, the six VgaA- or VgaAv-containing strains reported are the only isolates with retapamulin MICs of
2 µg/ml. In addition to demonstrating its low frequency, this suggests that reduced susceptibility to pleuromutilins will most commonly be due to the presence of a Vga protein.
Nucleotide sequence accession number.
The nucleotide sequence of pVGA has been submitted to the GenBank database and has been given the accession number FJ207465.

FOOTNOTES
* Corresponding author. Mailing address: UP1345, GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, PA 19426. Phone: (610) 917-7504. Fax: (610) 917-7901. E-mail:
dan.r.gentry{at}gsk.com 
Published ahead of print on 6 October 2008. 

REFERENCES
1 - Akopyants, N. S., A. Fradkov, L. Diatchenko, J. E. Hill, P. D. Siebert, S. A. Lukyanov, E. D. Sverdlov, and D. E. Berg. 1998. PCR-based subtractive hybridization and differences in gene content among strains of Helicobacter pylori. Proc. Natl. Acad. Sci. USA 95:13108-13113.[Abstract/Free Full Text]
2 - Augustin, J., R. Rosenstein, B. Wieland, U. Schneider, N. Schnell, G. Engelke, K. D. Entian, and F. Gotz. 1992. Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur. J. Biochem. 204:1149-1154.[Medline]
3 - Bouige, P., D. Laurent, L. Piloyan, and E. Dassa. 2002. Phylogenetic and functional classification of ATP-binding cassette (ABC) systems. Curr. Protein Pept. Sci. 3:541-559.[CrossRef][Medline]
4 - Chesneau, O., H. Ligeret, N. Hosan-Aghaie, A. Morvan, and E. Dassa. 2005. Molecular analysis of resistance to streptogramin A compounds conferred by the Vga proteins of staphylococci. Antimicrob. Agents Chemother. 49:973-980.[Abstract/Free Full Text]
5 - Haroche, J., J. Allignet, C. Buchrieser, and N. El Solh. 2000. Characterization of a variant of vga(A) conferring resistance to streptogramin A and related compounds. Antimicrob. Agents Chemother. 44:2271-2275.[Abstract/Free Full Text]
6 - Kreiswirth, B. N., S. Lofdahl, M. J. Betley, M. O'Reilly, P. M. Schlievert, M. S. Bergdoll, and R. P. Novick. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage 6. Nature 305:709-712.[CrossRef][Medline]
7 - Novotna, G., and J. Janata. 2006. A new evolutionary variant of the streptogramin A resistance protein, Vga(A)LC, from Staphylococcus haemolyticus with shifted substrate specificity towards lincosamides. Antimicrob. Agents Chemother. 50:4070-4076.[Abstract/Free Full Text]
8 - Novotna, G., J. Spizek, and J. Janata. 2007. In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes Folia Microbiol. (Praha) 52:593-599.
9 - Parish, L. C., and J. L. Parish. 2008. Retapamulin: A new topical antibiotic for the treatment of uncomplicated skin infections. Drugs Today (Barcelona). 44:91-102.
10 - Scangarella, N., C. Jakielaszek, L. McCloskey, D. Gentry, S. Rittenhouse, F. Shawar, and D. Payne. 2007. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. E-2089.
11 - Yan, K., L. Madden, A. E. Choudhry, C. S. Voigt, R. A. Copeland, and R. R. Gontarek. 2006. Biochemical characterization of the interactions of the novel pleuromutilin derivative retapamulin with bacterial ribosomes. Antimicrob. Agents Chemother. 50:3875-3881.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, December 2008, p. 4507-4509, Vol. 52, No. 12
0066-4804/08/$08.00+0 doi:10.1128/AAC.00915-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Kadlec, K., Schwarz, S.
(2009). Novel ABC Transporter Gene, vga(C), Located on a Multiresistance Plasmid from a Porcine Methicillin-Resistant Staphylococcus aureus ST398 Strain. Antimicrob. Agents Chemother.
53: 3589-3591
[Abstract]
[Full Text]